EPI-PHARE Launches Pharmacoepidemiology Projects for 2023
Funding is available to support research projects focussing on pharmacoepidemiology in France.
EPI-PHARE is a scientific interest group created in 2018 by the Agence nationale de sécurité du médicament et des produits de santé (ANSM – French National Security Agency of Medicines and Health Products) and the Caisse nationale d’assurance maladie (CNAM – National Health Insurance Fund). It aims to provide public authorities with independent expertise in the epidemiology of health products.
In order to help develop pharmacoepidemiology in France and to respond to the increasing numbers of pharmacoepidemiology studies, EPI-PHARE is opening a call for projects in 2023. This call is aimed at the academic scientific community and will fund pharmacoepidemiology studies.
The objective of the call is to initiate collaboration between EPI-PHARE and academic teams of research. Each proposal must be based on an innovative pharmacoepidemiology study project and be of national scope.
Research projects must be integrated into one of the strategic axes of the EPI-PHARE work programme.
In 2023, research projects that focus on the following topics are particularly encouraged:
- The misuse of new drugs.
- The use, effectiveness and risks of medical devices.
Any academic team with a research project in the epidemiology of health products that satisfy the eligibility criteria may apply.
Research teams that are involved in a project may belong to the following organisations:
- Public research organisations: universities, Public Scientific and Technological Establishments (EPST) and Public Industrial and Commercial Establishments (EPIC).
- Private not-for-profit research organisations (foundations, associations).
- Health establishments.
Each research project must be led by a single scientific coordinator. Coordinators and scientific managers of each partner should not be in situation of conflict of interest with the subject of their project.
The participation of foreign teams is possible if they provide their own funding and are independent of private interests.
The grants are provided by the ANSM and are of a maximum of €100,000. The maximum duration of research projects is 30 months.
Applications to the 2023 call must be submitted by the deadline of 1 June 2023 (12:00 Paris time).
(This report was the subject of a ResearchConnect Newsflash.)